Author： Raho Giovanna
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.30, Iss.11, 2012-11, pp. : 1005-1013
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging drugs for moderate-to-severe psoriasis
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. :
Access to resources
Recommend
Ustekinumab useful for moderate-to-severe plaque psoriasis
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :
Treatment failure rate, costs high in moderate-to-severe psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 473, 2005-01 ,pp. :
Ustekinumab: A Review of its Use in the Management of Moderate To Severe Plaque Psoriasis
Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. :